1 Human Performance Laboratory, Diabetes/Obesity Center, and 2 Departments of Exercise and Sport Science, and 3 Biochemistry, Medicine, Physiology, and Surgery, East Carolina University, Greenville, North Carolina 27858; and 4 Diabetes Unit, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The purpose of this study
was to determine whether the improved insulin action with short-term
exercise training in middle-aged individuals is associated with
enhanced phosphatidylinositol (PI) 3-kinase activity in skeletal
muscle. Nine men of ages 50-70 yr were studied before and after 7 consecutive days of supervised exercise (60 min/day, 70% peak
O2 consumption). Insulin sensitivity was measured with a
euglycemic hyperinsulinemic glucose clamp in the sedentary condition
and 15-17 h after the final exercise session.
Anti-phosphotyrosine-associated PI 3-kinase activity was determined
from muscle samples obtained in the fasted condition and after 60 min
of insulin infusion during the clamp. With exercise, the glucose
infusion rate increased (P < 0.001) by 33%,
indicating enhanced insulin action (mean ± SE, 6.6 ± 0.6 vs. 8.7 ± 0.8 mg · kg1 · min
1).
Short-term exercise training did not, however, increase
insulin-stimulated (insulin stimulated/fasting) PI 3-kinase activity
(1.8 ± 0.8 vs. 1.8 ± 0.7-fold stimulation with insulin pre-
vs. posttraining, respectively). There was also no change in
insulin-stimulated protein kinase B activity (1.3 ± 0.1 vs.
1.4 ± 0.2-fold stimulation with insulin) with training. These
data suggest that insulin action is enhanced with short-term exercise
training via an adaptation distal to PI 3-kinase in middle-aged,
insulin-resistant individuals.
aging; glucose transport; insulin resistance; physical activity; skeletal muscle
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
EXERCISE TRAINING
improves insulin action in middle- to older-aged individuals (7,
8, 18, 33). This effect occurs relatively rapidly, with
enhanced insulin action evident after as little as seven consecutive
days of physical activity [50-60 min/day at 50-75% peak
oxygen consumption (O2 peak)] (7, 8, 33). The ability to improve insulin action with exercise in an older population is important, because the insulin resistance of aging begins early in middle age (30-40 yr) and is
associated with an enhanced risk for coronary artery disease, obesity,
and type 2 diabetes (11, 13, 20, 31).
Although exercise improves insulin action in middle- to older-aged subjects, the cellular mechanisms involved are not yet evident. Recent findings have increased our understanding of the cellular events leading to insulin-stimulated glucose transport (for reviews see Refs. 10, 22, 34). Briefly, the process is initiated with ligand binding to the insulin receptor and tyrosine kinase activation that leads to phosphorylation and activation of a family of insulin receptor substrates (IRS). The subsequent docking of phosphatidylinositol (PI) 3-kinase to an IRS results in phosphorylated lipid products, which activate yet-undefined downstream signaling pathways (36). This signaling process ultimately induces translocation of the insulin-sensitive glucose transporter (GLUT-4) to skeletal muscle membranes and facilitates sugar transport into the cell (10, 21, 34, 36). After 7 days of exercise training, GLUT-4 and insulin action increased by the same relative magnitude in young and middle-aged subjects (8), indicating that older individuals retain the ability to respond to the exercise stimulus.
The effect of exercise training on the signaling events that induce GLUT-4 translocation are not, however, evident, particularly in aged skeletal muscle (16). Several studies have focused on PI 3-kinase, as this protein is directly involved in insulin-mediated glucose transport (10, 35, 36, 37). In young subjects, exercise training increased insulin-stimulated PI 3-kinase activity in conjunction with insulin action (19, 26). However, Cusi et al. (9) reported no improvement in insulin-stimulated PI 3-kinase activity in obese individuals and type 2 diabetics after a single exercise bout; insulin action was also not enhanced. This finding (9) suggests that the insulin-signaling pathway may also be resistant to the exercise training stimulus (i.e., consecutive days of exercise as opposed to a single exercise bout; Ref. 9) at the level of PI 3-kinase in insulin-resistant individuals. The effect of exercise training that improves insulin action on PI 3-kinase has not, however, been studied in an older insulin-resistant population. The purpose of the current study was, therefore, to examine the effect of a short-term exercise training protocol demonstrated to improve insulin action (8) on insulin-mediated PI 3-kinase activity in middle-aged subjects. Due to our previous finding of enhanced PI 3-kinase in young subjects with physical activity (19), our hypothesis was that insulin-stimulated PI 3-kinase activity in skeletal muscle from middle-aged individuals would increase with exercise training, in conjunction with improved insulin action.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Study design.
Subjects were assessed for suitability by an interview, health history
questionnaire, and medical clearance. Preliminary assessments included
body composition and a O2 peak test
1) to ensure that subjects were sedentary, 2) to
ensure that there was no overt evidence of heart disease, and
3) to calculate the workload used during exercise training.
After these preliminary measurements, a pretraining hyperinsulinemic
euglycemic clamp was administered with muscle biopsies performed before
and 60 min into the clamp. A period of 7 consecutive days of exercise
training (cycle ergometer) was initiated within 14 days of the clamp.
Fifteen to seventeen hours after the last training bout, a posttraining
hyperinsulinemic euglycemic clamp was administered, and muscle biopsies
were performed before and 60 min into the clamp. PI 3-kinase activity
was determined in all of the muscle samples, as this was the primary
focus of the study. There was sufficient material remaining in four
subjects to determine protein kinase B (Akt) activity.
Subjects. All subjects read and provided informed consent to acknowledge the risks and procedures involved before participating in this study. Approval by the East Carolina University Policy and Review Committee on Human Research was obtained before any testing was performed. Nine untrained, middle-aged (50-70 yr) Caucasian men were recruited as volunteers. Subjects exhibited no evidence of cardiovascular disease, were not taking medications that could affect carbohydrate metabolism or exercise tolerance, and did not have orthopedic difficulties that could hinder exercising. Subjects had not performed regular exercise for at least 2 yr before initiation of the study.
Body composition. Subjects were initially measured for height and mass. Mass was also measured before each training bout to ensure minimal alterations over the 7-day period. Subjects were instructed to consume an additional 300-400 kcal/day to offset the energy expended during exercise but not to alter any other aspects of diet. To characterize the health and obesity status of the subjects, body composition was initially estimated using the seven-site skinfold equation (21).
Hyperinsulinemic euglycemic glucose clamp.
The procedures used during the clamp have been summarized elsewhere
(17, 19) and were a modification of the method developed by DeFronzo et al. (12). Briefly, arterialized blood was
drawn from a heated hand vein to determine glucose and insulin levels. After determination of baseline glucose concentration, a primed continuous infusion of insulin (100 mU · m2 · min
1) was
started. We previously developed a time course for the PI 3-kinase
response to this insulin dosage in human skeletal muscle (17), and we have reported an increase in insulin action
and PI 3-kinase activity after short-term exercise training with this technique (19). Plasma glucose concentration was
determined every 5 min throughout the test (2300 STATplus, Yellow
Springs Instrument, Yellow Springs, OH), and adjustments were made, as necessary, in the rate of glucose infusion (M-value) to maintain euglycemia at fasting basal levels. Plasma for insulin concentration was obtained every 10 min and stored at
80°C. The clamp was
performed for 120 min. A microparticle enzyme immunoassay was used for
the subsequent measurement of plasma insulin with an Abbott IMx
analyzer (Abbott Laboratories, Abbott Park, IL). A steady-state M-value was determined from the final 30 min of the clamp (12).
Exercise training.
All exercise training was performed in the laboratory under the
supervision of an exercise physiologist (C. J. Tanner). Training duration was 60 min/session; frequency was 1 session/day for 7 consecutive days. Exercise intensity was maintained at 70% of the
subject's O2 peak by analysis of
expired gases every 5-15 min. Heart rate was continuously recorded
using a Polar heart rate monitor (Polar USA, Stamford, CT) to ensure an
adequate training intensity. This exercise program has been used
previously in this laboratory (8, 19) and by others
(7, 33) to improve insulin action without weight loss in
insulin-resistant individuals.
Muscle biopsy. Muscle samples of ~60 mg were obtained from the lateral portion of the vastus lateralis, before training and 15-17 h after the last training bout for the determination of PI 3-kinase and Akt activity. Before initiation of the clamp, a biopsy was obtained from the left leg as the basal, fasting sample. The second biopsy was obtained from the right leg after 60 min of insulin exposure. The same sequence was performed after the 7 days of training. Tissue was obtained 60 min into the clamp, as we have previously demonstrated optimal PI 3-kinase activation at this time point with the insulin dosage and clamp procedure used in the present study (17). Other studies (2, 40, 41) have also obtained muscle biopsies at similar time points (40-100 min) during a glucose clamp when measuring insulin-signaling events.
PI 3-kinase assay. PI 3-kinase activity was assayed after immunoprecipitation with an anti-phosphotyrosine antibody according to methods previously used in this (17, 19) and other (14, 15) laboratories. Skeletal muscle from the biopsies was homogenized in ice-cold buffer (1:10 wt/vol) containing 1% (vol) Nonidet P-40 for 30 s. The supernatant was incubated overnight at 4°C with anti-phosphotyrosine conjugated to agarose beads (Sigma A-1806). Labeled lipids were extracted with 300 µl of methanol-chloroform (1:1, vol/vol), reaction products were visualized on a phosphorimager, and radioactivity was quantified by densitometry. Results were normalized to protein content.
Akt assay. Akt activity was determined as previously described (23, 24). Twenty milligrams of muscle were homogenized using a polytron at one-half maximum speed for 1 min on ice in 500 ml of buffer A (in mM: 20 Tris, pH 7.5, 5 EDTA, 10 Na4P2O7, 100 NaF, 2 Na3VO4) containing 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, and 10 mg/ml leupeptin. Tissue lysates were solubilized by continuous stirring for 1 h at 4°C and centrifuged for 10 min at 14,000 g. Muscle lysates (200 mg protein) were subjected to immunoprecipitation for 4 h at 4°C with 3 mg of Akt antibody, which recognizes both Akt1 and Akt2 (Upstate Biotechnology, Lake Placid, NY) coupled to protein G-Sepharose beads (Pharmarcia Biotech, Piscataway, NJ). Immune pellets were washed, and Akt activity was determined as previously described (24, 25).
Statistical analysis. PI 3-kinase activity was expressed as degree of stimulation over fasting by dividing the measured activity after 60 min of insulin exposure by the fasting activity. Repeated-measures analysis of variance (ANOVA) on log-normalized and non-log-normalized data was used to test for a difference between insulin stimulation before and after short-term exercise training. All other variables were compared with repeated-measures ANOVA. Statistical significance was denoted at the P < 0.05 level, and data are presented as means ± SE.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Subjects.
Physical characteristics of the subjects are presented in Table
1. The exercise characteristics of the
subjects are presented in Table 2.
Subjects exercised at ~70% of
O2 peak during the training sessions.
Total body weight, which was measured each day immediately before
exercise, was not significantly altered during the 7 days of training
(P = 0.49).
|
|
Insulin action.
Fasting plasma insulin concentration tended to decrease with the 7 days
of training (8.8 ± 1.4 vs. 6.8 ± 1.4 µU/ml for pre- vs.
posttraining, respectively, P = 0.10). Fasting plasma
glucose concentration also tended to decrease with physical activity
(100.4 ± 5.1 vs. 97.0 ± 4.9 mg/dl, P = 0.09). There were no significant differences (P = 0.38)
in insulin or glucose concentration during the final 30 min of the
clamp for before vs. after short-term exercise training (Fig.
1).
|
|
PI 3-kinase activity.
Insulin-stimulated PI 3-kinase activity was expressed as mean degree of
stimulation over fasting activity and is depicted before and after the
7 days of exercise training in Fig. 3.
Mean insulin-stimulated PI 3-kinase activity did not change (1.8 ± 0.8 vs. 1.8 ± 0.7 mean degree of change over fasting for pre- vs. posttraining, respectively; P = 0.63) with
short-term training (Fig. 3). These degrees of increase in PI 3-kinase
activity with insulin were within the ranges reported in other studies
examining the skeletal muscle of insulin-resistant humans during a
glucose clamp [range 0-1.5 degree of stimulation over fasting
with insulin exposure (2, 9, 24, 28)]. Before the 7 days
of exercise training, insulin-stimulated
anti-phosphotyrosine-associated PI 3-kinase activity was not
statistically different (P = 0.93) from fasting PI
3-kinase activity (45.0 ± 16.0 vs. 67.9 ± 19.9 arbitrary units for fasting vs. insulin-stimulated activity, respectively). After
training, insulin again did not significantly increase
(P = 0.96) anti-phosphotyrosine-associated PI-3 kinase
activity over fasting activity (46.7 ± 13.9 vs. 67.1 ± 21.0 arbitrary units for fasting vs. insulin-stimulated activity,
respectively). These data are in agreement with findings obtained in
other in vivo studies of insulin-resistant subjects (2, 9,
24), where insulin did not significantly increase PI 3-kinase
activity over fasting activity in skeletal muscle.
|
Akt activity.
As presented in Fig. 4,
insulin-stimulated Akt activity did not change with exercise training.
Insulin infusion during the clamp enhanced Akt activity a mean of
1.3 ± 0.1-fold before exercise training and a mean of 1.4 ± 0.2-fold after training; these values were not significantly different
(P = 0.61). To our knowledge, there are no
insulin-stimulated Akt data in insulin-resistant human muscle for the
purpose of comparison. Insulin did not increase Akt activity compared
with fasting before training (2,357 ± 74 vs. 2,573 ± 112 arbitrary units for fasting vs. insulin stimulated, respectively;
P = 0.18). However, after training, insulin exposure did increase Akt activity compared with fasting (2,145 ± 158 vs. 2,704 ± 82 arbitrary units for fasting vs. insulin stimulated, respectively; P = 0.04).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
PI 3-kinase is an important regulatory step of insulin signal transduction in insulin-sensitive cells (36, 37). Studies utilizing various biochemical techniques and pharmaceutical agents have demonstrated that PI 3-kinase is a necessary component of insulin-mediated glucose transport (35-37). Thus, although the signaling components downstream of PI 3-kinase are not well characterized, a specific role for PI 3-kinase in insulin-stimulated glucose transport is apparent (35-37).
In previous work from our laboratory (19), an identical 7-day exercise training program increased insulin-stimulated PI 3-kinase activity about threefold compared with the nonexercising, sedentary condition in the skeletal muscle of young individuals (25 yr) in concordance with improved insulin action. In a cross-sectional design, Kirwan et al. (26) recently reported that insulin-stimulated IRS-1-associated PI 3-kinase activity was at least doubled in the skeletal muscle of young (mean age of 24 yr), endurance-trained subjects compared with their sedentary counterparts. In rodents, enhanced PI 3-kinase activity with insulin stimulation was reported after 1 and 5 days of exercise training (6). In contrast to these data, the main finding of the present study was that insulin-stimulated PI 3-kinase activity did not increase with short-term exercise training in the skeletal muscle of middle-aged men (Fig. 3). This result suggests that the insulin-signaling cascade, at least at the level of PI 3-kinase, may respond differently to the exercise training stimulus, depending upon the population examined.
The differing response of insulin-stimulated PI 3-kinase activity to exercise training in young (19, 26) vs. older individuals (Fig. 3) may involve obesity status and the initial presence of insulin resistance. It has been reported that aging (5), obesity (9, 15, 25), and type 2 diabetes (2, 9, 24) dramatically decrease the responsiveness of PI 3-kinase to insulin. For example, Carvalho et al. (5) reported an ~90% decline in insulin-stimulated PI 3-kinase activity in skeletal muscle from young (2 mo) vs. aged (20 mo) male Wistar rats. In type 2 diabetic and obese subjects, insulin-stimulated anti-phosphotyrosine-associated PI 3-kinase activity in skeletal muscle is virtually abolished (2, 9), as was the case in the present study (RESULTS, Fig. 3). A marked inability to activate PI 3-kinase with insulin is thus displayed in conditions typically associated with insulin resistance.
In an attempt to overcome this resistance in activation of PI
3-kinase, Cusi et al. (9) subjected obese subjects or
individuals with type 2 diabetes to a single, relatively mild (60 min,
65% O2 max) exercise bout and studied
components of the insulin-signaling pathway 24 h after the
exercise session. In these insulin-resistant individuals, a single
exercise bout did not increase either insulin-stimulated IRS-1 or
phosphotyrosine-associated PI 3-kinase activity, nor did it enhance
insulin action compared with preexercise values (9).
Phosphorylation of the insulin receptor and IRS-1 along with glycogen
synthase activity did, however, increase. These authors
(9) concluded that a single bout of exercise could not
overcome the defect in the insulin-signaling pathway present with
insulin resistance and that PI 3-kinase defines a key step in the
insulin-resistant state. The current data provide the important additional information that insulin signal transduction at the level of
PI 3-kinase is not altered with the more robust intervention of
short-term exercise training that improves insulin action in insulin-resistant subjects (Figs. 2 and 3). This novel finding suggests
that adaptations downstream of PI 3-kinase or alternate insulin-signaling pathways may be responsible for the improvement in
insulin action with physical activity in middle-aged, insulin-resistant subjects.
To examine other potential mechanisms, we measured the activity of an additional insulin-signaling element. Akt is hypothesized to be the next step distal to PI 3-kinase in the insulin-signaling process for glucose transport (4, 27). Insulin-stimulated Akt activity can also be reduced in the insulin-resistant state (24, 28). In agreement with our PI 3-kinase data, we observed no increase in the activation of Akt with insulin after training (Fig. 4). It must be considered, however, that the Akt data were obtained in a small subset of subjects and that exercise may have different effects on the individual isoforms of Akt.
Because the magnitude of the insulin signal did not appear to change, another factor may be responsible for the improvement in insulin action with training (Fig. 2). Systemic factors such as increased muscle blood flow with training may enhance insulin-mediated glucose uptake (1). In relation to skeletal muscle, the overexpression of GLUT-4 in transgenic mice produces an approximately twofold increase in protein concentration, which is similar in scope to the exercise training response (8, 16, 18, 29, 32, 38, 39). In these transgenic animals, insulin sensitivity is enhanced. It was suggested (3) that, in obese Zucker rats, the increase in GLUT-4 with training alone compensated for the defect in insulin-stimulated GLUT-4 translocation. These data suggest that the presence of additional insulin-sensitive glucose transporters in skeletal muscle with exercise training may be sufficient to enhance whole body insulin action without an accompanying amplification of the insulin-signaling process. In support of this hypothesis, in previous work from our laboratory (8), GLUT-4 concentration increased approximately twofold in conjunction with enhanced insulin action after an identical 7-day exercise training program in similar middle-aged men. This finding (8) suggests that GLUT-4 increased to a extent similar to that in the current study, although we did not measure the concentration of this protein again.
It must be acknowledged that some aspect(s) of the insulin-signaling cascade may also have been overlooked with the current experimental design. For example, a yet-unidentified signaling step distal to PI 3-kinase or Akt could be enhanced with exercise, as well as an alternative insulin-signaling system. Also, in the present study, total PI 3-kinase activity was determined after immunoprecipitation with a phosphotyrosine antibody. This approach was used because it measures ~95% of the activated PI 3-kinase (30); we have also observed a relationship between total PI 3-kinase activity and insulin-mediated glucose uptake in humans (17). It is possible that IRS-1- or IRS-2-associated PI 3-kinase activity may have been differentially affected with training (6). There are also seven insulin-regulated PI 3-kinase isoforms, which may exhibit separate responses to training (23, 35). It must be considered, however, that phosphotyrosine-associated PI 3-kinase activation was enhanced after 7 days of training in young individuals with the use of identical methods in our laboratory (19). It is thus logical to assume that the methodology used would have detected an increase in PI 3-kinase activity with exercise.
Exercise training improves insulin action through both acute effects from the last training bout and the chronic accumulation of successive exercise sessions (16). The current experiment was not designed to distinguish between acute and chronic influences of physical activity on insulin action. Rather, we utilized the 7-day model because it has been demonstrated to enhance insulin action in insulin-resistant subjects without a confounding change in body mass (7, 8, 33; RESULTS). An interesting finding was that exercise improved insulin action by the same relative magnitude (~30%) in both young and middle-aged subjects when we compared the current findings with previous data from our laboratory (19). This finding indicates that middle-aged individuals maintain the ability to adapt to an exercise stimulus and improve insulin action. The cellular mechanism(s) involved still, however, remains largely undefined.
In summary, a 7-day exercise training program significantly improved insulin action in insulin-resistant, middle-aged men. The improvement in insulin action with exercise was not accompanied by enhanced insulin signal transduction at the level of PI 3-kinase or Akt in skeletal muscle. These data suggest that short-term exercise training enhances insulin action in middle-aged individuals via an adaptation distal to PI 3-kinase.
![]() |
ACKNOWLEDGEMENTS |
---|
Special thanks to the Diabetes/Obesity Center at the Brody School of Medicine and Pitt County Community Hospital for providing the use of their facilities.
![]() |
FOOTNOTES |
---|
This research was supported by grants from the American College of Sports Medicine Foundation (J. A. Houmard) and AG-1004 (J. A. Houmard).
Address for reprint requests and other correspondence: C. J. Tanner, Human Performance Laboratory, Ward Sports Medicine Bldg., East Carolina University, Greenville, NC 27858 (TANNERC{at}MAIL.ECU.EDU).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 13 February 2001; accepted in final form 20 August 2001.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Baron, AD.
The coupling of glucose metabolism and perfusion in human skeletal muscle: the potential role of endothelium-derived nitric oxide.
Diabetes
45, Suppl 1:
S105-S109,
1996[ISI][Medline].
2.
Bjornholm, M,
Kawano Y,
Lehtihet M,
and
Zierath JR.
Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.
Diabetes
46:
524-527,
1997[Abstract].
3.
Brozinick, JT,
Etgen GJ,
Yaspelkis BB,
Kang HY,
and
Ivy JL.
Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats.
Am J Physiol Endocrinol Metab
265:
E419-E427,
1993
4.
Burgering, BM,
and
Coffer PJ.
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.
Nature
376:
599-562,
1995[ISI][Medline].
5.
Carvalho, CRO,
Brenelli SL,
Silvia AC,
Nunes ALB,
Velloso LA,
and
Saad MJA
Effect of aging on insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in liver and muscle of rats.
Endocrinology
137:
151-159,
1996[Abstract].
6.
Chibalin, AV,
Yu M,
Ryder JW,
Song XM,
Galuska D,
Krook A,
Walberg-Henriksson H,
and
Zierath JR.
Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2.
Proc Natl Acad Sci USA
97:
38-43,
2000
7.
Cononie, CC,
Goldberg AP,
Rogus E,
and
Hagberg JM.
Seven consecutive days of exercise lowers plasma insulin responses to an oral glucose challenge in sedentary elderly.
J Am Geriatr Soc
42:
394-398,
1994[ISI][Medline].
8.
Cox, JH,
Cortright RN,
Dohm GL,
and
Houmard JA.
Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity.
J Appl Physiol
86:
2019-2025,
1999
9.
Cusi, K,
Maezono K,
Osman A,
Pendergrass M,
Patti ME,
Pratipanwatr T,
DeFronzo RA,
Kahn CR,
and
Manderino LJ.
Insulin resistance differentially affects the PI 3-kinase and MAP kinase-mediated signaling in human muscle.
J Clin Invest
105:
311-320,
2000
10.
Czech, MP,
and
Covera S.
Signaling mechanisms that regulate glucose transport.
J Biol Chem
274:
1865-1868,
1999
11.
DeFronzo, RA.
Glucose intolerance and aging.
Diabetes Care
4:
493-501,
1981[Abstract].
12.
DeFronzo, RA,
Tobin JD,
and
Andres R.
Glucose clamp technique: a method for quantifying secretion and resistance.
Am J Physiol Endocrinol Metab Gastrointest Physiol
237:
E214-E223,
1979
13.
Feskins, EJM,
and
Kromhout D.
Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen Elderly Study.
Arterioscler Thromb
14:
1641-1647,
1994[Abstract].
14.
Goodyear, LJ,
Giorgino F,
Balon TW,
Condorelli G,
and
Smith RJ.
Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle.
Am J Physiol Endocrinol Metab
268:
E987-E995,
1995
15.
Goodyear, LJ,
Giorgino F,
Sherman LA,
Carey J,
Smith RJ,
and
Dohm GL.
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese patients.
J Clin Invest
95:
2195-2204,
1995[ISI][Medline].
16.
Goodyear, LJ,
and
Kahn BB.
Exercise, glucose transport, and insulin sensitivity.
Annu Rev Med
49:
235-261,
1998[ISI][Medline].
17.
Hickey, MS,
Tanner CJ,
O'Neill DS,
Morgan LJ,
Dohm GL,
and
Houmard JA.
Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo.
J Appl Physiol
83:
718-722,
1997
18.
Houmard, JH,
Egan PC,
Neufer PD,
Friedman WS,
Israel RG,
and
Dohm GL.
Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men.
Am J Physiol Endocrinol Metab
261:
E437-E443,
1991
19.
Houmard, JA,
Shaw CD,
Hickey MS,
and
Tanner CJ.
Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle.
Am J Physiol Endocrinol Metab
277:
E1055-E1060,
1999
20.
Jackson, RA.
Mechanisms of age-related glucose intolerance.
Diabetes Care
13, Suppl 2:
9-19,
1990[Abstract].
21.
Jackson, AS,
and
Pollock ML.
Generalized equations for predicting body density of men.
Br J Nutr
40:
497-504,
1978[ISI][Medline].
22.
Kahn, CR.
Insulin action, diabetogenes, and the cause of type II diabetes.
Diabetes
43:
1066-1084,
1994[ISI][Medline].
23.
Kerouz, NJ,
Horsch JD,
Pons S,
and
Kahn CR.
Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.
J Clin Invest
100:
3164-3172,
1997
24.
Kim, Y-B,
Nikoulina SE,
Ciaraldi TP,
Henry RR,
and
Kahn BB.
Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation phosphoinositide 3-kinase, in muscle in type 2 diabetes.
J Clin Invest
104:
733-741,
1999
25.
Kim, Y-B,
Peroni OD,
Franke TF,
and
Kahn BB.
Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats.
Diabetes
49:
847-856,
2000[Abstract].
26.
Kirwan, JP,
Del Aguila LF,
Hernandez JM,
Williamson DL,
O'Gorman DJ,
Lewis R,
and
Krishnan RK.
Regular exercise enhances insulin activation of IRS-1 associated PI 3-kinase in human skeletal muscle.
J Appl Physiol
88:
797-803,
2000
27.
Kohn, AD,
Kovacina KS,
and
Roth RA.
Insulin stimulated the kinase activity of RAC-PK, a pleckstrin homology by domain containing ser/thr kinase.
EMBO J
14:
4288-4295,
1995[Abstract].
28.
Krook, A,
Roth RA,
Jiang XJ,
Zierath JR,
and
Wallberg-Henriksson H.
Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects.
Diabetes
47:
1281-1286,
1998[Abstract].
29.
Leturque, A,
Loizeau M,
Baulont S,
Salminen M,
and
Girard J.
Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle.
Diabetes
45:
23-27,
1996[Abstract].
30.
Okamoto, M,
Hayashi T,
Kono S,
Inoue G,
Kubota M,
Kuzuya H,
and
Imura H.
Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation.
Biochem J
290:
327-333,
1993[ISI][Medline].
31.
Reaven, GM.
Pathophysiology of insulin resistance in human disease.
Physiol Rev
75:
473-486,
1995
32.
Ren, J-M,
Marshall BA,
Mueckler MM,
McCaleb M,
Amatruda JM,
and
Shulman GI.
Overexpression of GLUT4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.
J Clin Invest
95:
429-432,
1995[ISI][Medline].
33.
Rogers, MA,
Yamamoto C,
King DS,
Hagberg JM,
Ehsani AA,
and
Holloszy JO.
Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM.
Diabetes Care
11:
613-618,
1988[Abstract].
34.
Saltiel, AR.
Diverse signaling pathways in the cellular actions of insulin.
Am J Physiol Endocrinol Metab
270:
E375-E385,
1996
35.
Shepherd, PR,
Nave BT,
Rincon J,
Nolte LA,
Bevan AP,
Siddle K,
Zierath JR,
and
Wallberg-Henriksson H.
Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human muscle.
J Biol Chem
272:
19000-19007,
1997
36.
Shepherd, PR,
Withers DJ,
and
Siddle K.
Phosphoinositide 3-kinase: the key switch in insulin signaling.
Biochem J
333:
471-490,
1998[ISI][Medline].
37.
Teruachi, Y,
Tsuji Y,
Satoh S,
Minoura H,
Murkami K,
Okuno A,
Inukai K,
Asano T,
Kaburagi T,
Ueki K,
Nakajima H,
Hanafusa T,
Matsuzawa Y,
Sekihara H,
Yin Y,
Barrett JC,
Oda H,
Tishikawa Akanuma Y,
Komuro I,
Suzuki M,
Yamamura K,
Kodama T,
Suzuki H,
Koyasu S,
Aizawa S,
Tobe K,
Fukui Y,
Yazaki Y,
and
Kadowaki T.
Increased insulin sensitivity and hypoglycemia in mice lacking the p85 subunit of phosphoinositide 3-kinase.
Nat Genet
21:
230-235,
1999[ISI][Medline].
38.
Tsao, T-S,
Burcelin R,
Katz EB,
and
Charron MJ.
Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.
Diabetes
45:
28-36,
1996[Abstract].
39.
Tsao, T-S,
Katz EB,
Pommer D,
and
Charron MJ.
Amelioration of insulin resistance but not hyperinsulinemia in obese mice overexpressing GLUT4 selectively in skeletal muscle.
Metabolism
49:
340-346,
2000[ISI][Medline].
40.
Wojtaszewski, JFP,
Hansen BF,
Gade J,
Kiens B,
Markuns JF,
Goodyear LJ,
and
Richter EA.
Insulin signaling and insulin sensitivity after exercise in human skeletal muscle.
Diabetes
49:
325-331,
2000
41.
Wojtaszewski, JFP,
Hansen BF,
Kiens B,
and
Richter EA.
Insulin signaling in human skeletal muscle: time course and effect of exercise.
Diabetes
46:
1775-1781,
1997[Abstract].